MSKCC/Motzer Score Metastatic RCC

Loading...

Time from diagnosis to systemic treatment < 1 year

Hemoglobin < lower limit of normal

Calcium > 10 mg/dL (> 2.5 mmol/L)

LDH > 1.5x upper limit of normal (normal: 140 U/L)

Performance status < 80% (Karnofsky)

References

T Powles. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2024
Robert J Motzer. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN, 2022
D. Heng. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009
T. Mekhail. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005
R. Motzer. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999
Reference - 10.1016/j.annonc.2024.05.537\
Reference - 10.1016/j.annonc.2021.09.014\